Smile-Link Healthcare Global Berhad (KLSE:SMILE)
Malaysia · Delayed Price · Currency is MYR 0.1000
+0.0050 (5.26%)
At close: Apr 29, 2026
KLSE:SMILE Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 23.67 | 27.35 | 33.52 | 35.35 | 34.53 | |
Revenue Growth | -13.47% | -18.39% | -5.18% | 2.38% | 11.40% |
Cost of Revenue | 12.8 | 14.39 | 21.32 | 17.32 | 15.19 |
Gross Profit | 10.87 | 12.96 | 12.19 | 18.03 | 19.33 |
Selling, General & Admin | 12.99 | 15.92 | 14.78 | 16.82 | 16.8 |
Other Operating Expenses | -0.4 | -1.53 | -0.34 | -0.04 | -0.03 |
Operating Expenses | 12.59 | 14.38 | 14.44 | 16.78 | 16.77 |
Operating Income | -1.71 | -1.42 | -2.24 | 1.24 | 2.56 |
Interest Expense | -0.33 | -0.74 | -1.31 | -1.04 | -1.02 |
Interest & Investment Income | - | 0 | 0.01 | - | 0 |
Currency Exchange Gain (Loss) | - | 0.03 | 0.03 | - | - |
Other Non Operating Income (Expenses) | 0 | -0.27 | - | 0 | - |
EBT Excluding Unusual Items | -2.04 | -2.39 | -3.51 | 0.2 | 1.54 |
Gain (Loss) on Sale of Assets | - | 2.45 | 0.26 | - | 0.05 |
Other Unusual Items | - | 0.11 | 0.37 | - | - |
Pretax Income | -2.04 | 0.17 | -2.89 | 0.2 | 1.59 |
Income Tax Expense | 0.21 | 0.33 | -0.26 | 0.06 | 0.55 |
Earnings From Continuing Operations | -2.26 | -0.16 | -2.63 | 0.14 | 1.04 |
Minority Interest in Earnings | -0.01 | -0.11 | -0.15 | -0.05 | -0.04 |
Net Income | -2.27 | -0.27 | -2.78 | 0.09 | 1 |
Net Income to Common | -2.27 | -0.27 | -2.78 | 0.09 | 1 |
Net Income Growth | - | - | - | -90.91% | - |
Shares Outstanding (Basic) | 244 | 252 | 250 | 250 | 250 |
Shares Outstanding (Diluted) | 340 | 252 | 250 | 351 | 250 |
Shares Change | 34.60% | 0.73% | -28.57% | 39.99% | 0.01% |
EPS (Basic) | -0.01 | -0.00 | -0.01 | 0.00 | 0.00 |
EPS (Diluted) | -0.01 | -0.00 | -0.01 | 0.00 | 0.00 |
EPS Growth | - | - | - | -93.52% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 0.65 | 4.06 | 3.43 | 0.03 | -0.29 |
Free Cash Flow Per Share | 0.00 | 0.02 | 0.01 | - | -0.00 |
Dividend Per Share | - | - | - | - | 0.001 |
Dividend Growth | - | - | - | - | -50.00% |
Gross Margin | 45.94% | 47.39% | 36.39% | 50.99% | 56.00% |
Operating Margin | -7.24% | -5.19% | -6.69% | 3.51% | 7.42% |
Profit Margin | -9.58% | -0.97% | -8.29% | 0.26% | 2.90% |
Free Cash Flow Margin | 2.74% | 14.86% | 10.23% | 0.09% | -0.83% |
EBITDA | 0.08 | 0.42 | 0.04 | 3.37 | 5.6 |
EBITDA Margin | 0.33% | 1.53% | 0.11% | 9.54% | 16.21% |
D&A For EBITDA | 1.79 | 1.84 | 2.28 | 2.13 | 3.03 |
EBIT | -1.71 | -1.42 | -2.24 | 1.24 | 2.56 |
EBIT Margin | -7.24% | -5.19% | -6.69% | 3.51% | 7.42% |
Effective Tax Rate | - | 191.76% | - | 31.68% | 34.76% |